Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-21-017675

President & CEO sold 1,024 shares at $55.19 ($56,515)

  • President & CEO acquired 26,515 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Simon, Christopher President & CEO 2021-05-18 Grant or award +26,515 196,745 D: show line 1 in the form
Simon, Christopher President & CEO 2021-05-19 Sale −1,024 $55.19 $56,515 195,721 D: show line 2 in the form
Open-market sales · 1,024 sh · avg $55.19 · $56,515

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Simon, Christopher President & CEO 2021-05-18 Grant or award · Non-qualified Stock Option (Right to Buy) +71,733 71,733 D: show line 3 in the form
Loading xslF345X03/form4.xml…